SCANDINAV. REAL HEART AB
Scandinavian Real Heart AB (Publ) designs and develops an artificial heart. The company engages in developing Realheart TAH to treat advanced stage heart failure. It also develops RealVAD, pulsating left ventricle assist; PulsePump, pulsating flow for heart and lung machines; and Sternal Prosthesis, to fix the sternum after open-chest surgery. The company was incorporated in 2007 and is based in … Read more
SCANDINAV. REAL HEART AB (782) - Net Assets
Latest net assets as of : €- EUR
Based on the latest financial reports, SCANDINAV. REAL HEART AB (782) has net assets worth €- EUR as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€-) and total liabilities (€-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
SCANDINAV. REAL HEART AB - Net Assets Trend (None–None)
This chart illustrates how SCANDINAV. REAL HEART AB's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for SCANDINAV. REAL HEART AB (None–None)
The table below shows the annual net assets of SCANDINAV. REAL HEART AB from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to SCANDINAV. REAL HEART AB's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
SCANDINAV. REAL HEART AB Competitors by Market Cap
The table below lists competitors of SCANDINAV. REAL HEART AB ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
TMP Group S.p.A.
F:A72
|
$33.16K |
|
BYD ELECTRONIC (4BY.SG)
STU:4BY
|
$33.18K |
|
Turn Therapeutics Inc. Common Stock
NASDAQ:TTRX
|
$33.19K |
|
NEW HOPE CORPN (OD8.SG)
STU:OD8
|
$33.21K |
|
Samad Misr -EGYFERT
EGX:SMFR
|
$33.15K |
|
UCORE RARE METS
BE:U9U
|
$33.14K |
|
BRISCOE GROUP
BE:BWU
|
$33.12K |
|
WINDSTREAM HLDGS
F:B4O
|
$33.10K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in SCANDINAV. REAL HEART AB's equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares SCANDINAV. REAL HEART AB's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently SCANDINAV. REAL HEART AB utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares SCANDINAV. REAL HEART AB's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $253,026,393
- Average return on equity (ROE) among peers: -74.55%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| SCANDINAV. REAL HEART AB (782) | €- | N/A | N/A | $33.16K |
| HeraMED Limited (1I4) | $-105.98K | 0.00% | 0.00x | $17.10 Million |
| Q-linea AB (publ) (3F80) | $163.19 Million | -164.65% | 0.41x | $9.23 Million |
| Guerbet SA (4G8) | $342.14 Million | 13.51% | 1.79x | $44.77 Million |
| Scandinavian Real Heart AB (Publ) (7820) | $111.29 Million | -9.42% | 0.06x | $4.77 Million |
| aap Implantate AG (AAQ1) | $54.78 Million | 26.71% | 0.17x | $9.65 Million |
| Carmat SA (CXT) | $7.48 Million | -557.76% | 3.92x | $1.62 Million |
| elexxion AG (E8X) | $-0.01 | 0.00% | 0.00x | $199.10K |
| AETHLON MEDIC.NEW DL-001 (EJU) | $15.06 Million | -79.86% | 0.16x | $446.12K |
| Eckert & Ziegler Strahlen- und Medizintechnik AG (EUZ) | $139.44 Million | 15.79% | 0.97x | $610.05 Million |
| Gaush Meditech Ltd (F7Y) | $1.70 Billion | 10.23% | 0.68x | $29.55 Million |